The aim of this guide is to provide its readers with a pragmatic overview of the law and practice of pharmaceutical advertising law across a variety of jurisdictions.
Each chapter of this guide provides information about the current issues affecting pharmaceutical advertising in a particular country and addresses topics such as self-regulation, press releases, gifts, samples, grants or donations, anti-bribery rules, regulatory authorities and courts, as well as insight and opinion on the most common issues in their respective country.
The Q&A template for each chapter has been provided by Nikki Reeves of King & Spalding LLP.
Use the tabs below to access our Hot Topics and Legal Landscape content.
Hot Topics explore specific issues in greater depth, including those with cross‑border relevance.
Legal Landscapes share authors’ views on the year ahead, highlighting key opportunities, risks, technological impacts, and guidance for clients.
The aim of this guide is to provide its readers with a pragmatic overview of the law and practice of pharmaceutical advertising law across a variety of jurisdictions.
Each chapter of this guide provides information about the current issues affecting pharmaceutical advertising in a particular country and addresses topics such as self-regulation, press releases, gifts, samples, grants or donations, anti-bribery rules, regulatory authorities and courts, as well as insight and opinion on the most common issues in their respective country.
The Q&A template for each chapter has been provided by Nikki Reeves of King & Spalding LLP.
Use the tabs below to access our Hot Topics and Legal Landscape content.
Hot Topics explore specific issues in greater depth, including those with cross‑border relevance.
Legal Landscapes share authors’ views on the year ahead, highlighting key opportunities, risks, technological impacts, and guidance for clients.
